Microbot Medical Inc.
MBOT
$1.46
-$0.04-2.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -60.77% | -41.14% | -2.12% | -11.26% | -41.99% |
| Total Depreciation and Amortization | 25.00% | -20.00% | -61.54% | -56.52% | -14.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 272.88% | -100.00% | 83.04% | -41.28% | -64.35% |
| Change in Net Operating Assets | -77.04% | -156.25% | -159.05% | -388.82% | 388.96% |
| Cash from Operations | -93.90% | -75.82% | -122.24% | -39.22% | -31.48% |
| Capital Expenditure | -1,477.78% | -730.77% | -257.14% | -- | -125.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 454.85% | 120.57% | -200.40% | -32,027.86% | -209.24% |
| Cash from Investing | 441.56% | 120.12% | -202.54% | -32,037.14% | -210.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.66% | -- | -11.51% | 7,984.68% | 129.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.66% | -- | -11.51% | 7,984.68% | 129.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.70% | -154.90% | -205.65% | 232.07% | -33.23% |